{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:49:39Z","timestamp":1793386179414,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>In October 2021, the World Health Organization (WHO) recommended the RTS,S\/AS01<jats:sub>E<\/jats:sub> (RTS,S) malaria vaccine for the prevention of <jats:italic>Plasmodium falciparum<\/jats:italic> malaria in children living in endemic areas informed by evidence from the subnational pilot introduction and evaluation in Ghana, Kenya, and Malawi as part of the WHO-coordinated Malaria Vaccine Implementation Programme (MVIP). With the global vaccine supply boosted by the pre-qualification of a second malaria vaccine, R21\/Matrix-M (R21), in October 2023, many endemic countries (20 as of April 2025) have introduced malaria vaccines into their national childhood immunization and malaria control programmes. More endemic countries are expected to introduce or scale up malaria vaccines in 2025 and beyond. This paper summarizes key operational lessons from the pilot countries to facilitate the introduction and scale-up of malaria vaccination in other countries.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Pilot areas were identified, in part, based on local malaria epidemiology. RTS,S was initially introduced in randomly selected areas, while other areas served as comparators until the four-dose schedule vaccine was scaled up following the WHO recommendation in 2021. In Ghana and Kenya, the vaccine was administered at ages 6, 7, 9, and 24\u00a0months (Ghana switched to administer the fourth dose at age 18\u00a0months in 2023), and Malawi chose a schedule of 5, 6, 7, and 22\u00a0months.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Vaccination coverage improved over time, reaching about 80% for the first dose and around 75% for the third dose by 2023 in the initial pilot areas. Implementation challenges included an inadequate understanding of age eligibility among healthcare workers during the early phase of introduction, low fourth dose coverage (with a median coverage of 46% in 2023 across the three countries), and disruptions to service delivery caused by disease outbreaks and other natural disasters. Health stakeholders and caregivers attested to the positive impact of introducing the malaria vaccine, including a reduction in malaria hospitalizations and the strengthening of the National Immunization Programme (NIP) through routine immunization refresher training and supportive supervision.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The pilot highlighted lessons for malaria vaccine introduction: (1) clearly outlined roles and responsibilities of key stakeholders including NIP and National Malaria Programme (NMP); (2) appropriate approach to vaccine introduction launch, communication, and demand generation to enhance vaccine uptake; (3) flexibility with dose scheduling to optimize coverage; and (4) updated data collection tools for accurate documentation, and data quality.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12936-025-05484-6","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T15:15:20Z","timestamp":1753715720000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Subnational introduction of the RTS,S\/AS01E malaria vaccine into routine immunization: experience and lessons from the three pilot countries"],"prefix":"10.1186","volume":"24","author":[{"given":"Rose","family":"Jalang\u2019o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwame","family":"Amponsa-Achiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Chisema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keziah","family":"Malm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydiah","family":"Khalayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Mhone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wahjib","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin","family":"Asiedu-Bekoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Haji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Njoroge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boston","family":"Zimba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Chirwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter O.","family":"Tweneboah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson","family":"Sillah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mgaywa G. M. D.","family":"Magafu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Bergstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Walldorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Kelleher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliane","family":"Pellaux-Furrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary J.","family":"Hamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Adjei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafiq N. A.","family":"Okine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"5484_CR1","volume-title":"World Malaria Report 2024","author":"WHO","year":"2024","unstructured":"WHO. World Malaria Report 2024. Geneva: World Health Organization; 2024."},{"key":"5484_CR2","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/S0140-6736(24)00004-7","volume":"403","author":"KP Asante","year":"2024","unstructured":"Asante KP, Mathanga DP, Milligan P, Akech S, Oduro A, Mwapasa V, et al. Feasibility, safety, and impact of the RTS, S\/AS01E malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi. Lancet. 2024;403:1660\u201370.","journal-title":"Lancet"},{"key":"5484_CR3","unstructured":"European Medicines Agency. First malaria vaccine receives positive scientific opinion from EMA 2015. https:\/\/www.ema.europa.eu\/en\/news\/first-malaria-vaccine-receives-positive-scientific-opinion-ema. Accessed 7 July 2025."},{"key":"5484_CR4","unstructured":"World Health Organization. Full evidence report on the RTS,S\/AS01 malaria vaccine. Geneva, World Health Organization. 2021. https:\/\/cdn.who.int\/media\/docs\/default-source\/immunization\/mvip\/full-evidence-report-on-the-rtss-as01-malaria-vaccine-for-sage-mpag-(sept2021).pdf. Accessed 8 July 2025."},{"key":"5484_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12936-019-2709-y","volume":"18","author":"R Yankson","year":"2019","unstructured":"Yankson R, Anto EA, Chipeta MG. Geostatistical analysis and mapping of malaria risk in children under 5 using point-referenced prevalence data in Ghana. Malar J. 2019;18:67.","journal-title":"Malar J"},{"key":"5484_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-023-04502-9","volume":"22","author":"T Hollowell","year":"2023","unstructured":"Hollowell T, Sewe MO, Rockl\u00f6v J, Obor D, Odhiambo F, Ahlm C. Public health determinants of child malaria mortality: a surveillance study within Siaya County, Western Kenya. Malar J. 2023;22: 65.","journal-title":"Malar J"},{"key":"5484_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e03946","author":"RT Gaston","year":"2020","unstructured":"Gaston RT, Ramroop S. Prevalence of and factors associated with malaria in children under five years of age in Malawi, using malaria indicator survey data. Heliyon. 2020. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03946.","journal-title":"Heliyon"},{"key":"5484_CR8","volume-title":"Malaria vaccines: WHO position paper","author":"WHO","year":"2024","unstructured":"WHO. Malaria vaccines: WHO position paper. Geneva: World Health Organization; 2024."},{"key":"5484_CR9","unstructured":"GAVI. Routine malaria vaccinations 2024. https:\/\/www.gavi.org\/news-resources\/media-room\/communication-toolkits\/routine-malaria-vaccinations. Accessed 7 July 2025."},{"issue":"Suppl_1","key":"5484_CR10","doi-asserted-by":"publisher","first-page":"S130","DOI":"10.1093\/infdis\/jiw544","volume":"216","author":"S Scotney","year":"2017","unstructured":"Scotney S, Snidal S, Saidu Y, Ojumu A, Ngatia A, Bagana M, et al. Succeeding in new vaccine introduction: lessons learned from the introduction of inactivated poliovirus vaccine in Cameroon, Kenya, and Nigeria. J Infect Dis. 2017;216(Suppl_1):S130\u20136.","journal-title":"J Infect Dis"},{"key":"5484_CR11","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1186\/s12889-023-15481-6","volume":"23","author":"MR Adjei","year":"2023","unstructured":"Adjei MR, Amponsa-Achiano K, Okine R, Tweneboah PO, Sally ET, Dadzie JF, et al. Post introduction evaluation of the malaria vaccine implementation programme in Ghana, 2021. BMC Public Health. 2023;23:586.","journal-title":"BMC Public Health"},{"issue":"1","key":"5484_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12936-023-04505-6","volume":"22","author":"Z Elnour","year":"2023","unstructured":"Elnour Z, Grethe H, Siddig K, Munga S. Malaria control and elimination in Kenya: economy-wide benefits and regional disparities. Malar J. 2023;22(1):117.","journal-title":"Malar J"},{"key":"5484_CR13","unstructured":"Price J, Collymore Y, Bawa JT, Mkisi R, Wanjala R, Buell C, et al. Recommendations to mitigate barriers to uptake and delivery of a four-dose malaria vaccine schedule: insights from the MVIP\u2019s qualitative evidence. J Price pers commun. Accessed 02 May 2025."},{"key":"5484_CR14","unstructured":"World Health Organization. Essential Training Packages for Malaria Vaccine Introduction. Geneva, World Health Organization, 2025. https:\/\/www.who.int\/publications\/m\/item\/essential-training-package-for-malaria-vaccine-introduction. Accessed 7 July 2025."},{"key":"5484_CR15","unstructured":"PATH. Quiz: Understanding the RTS,S malaria vaccine schedule and when children can receive the vaccine 2020. https:\/\/form.typeform.com\/to\/gEFKoniS?typeform-source=ndean.typeform.com. Accessed 8 July 2025."},{"key":"5484_CR16","unstructured":"PATH. Healthcare worker job aid on eligibility 2020. https:\/\/www.dropbox.com\/scl\/fo\/dikpgfb9h93zonpeorwox\/AMwQ-WftPspJx67JdZbr3R4?e=1&preview=rtss+eligibility+ghana+2023+HD+00.mp4&rlkey=5139rovau6enlkv1pfn286vyb&dl=0. Accessed 8 July 2025."},{"key":"5484_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11121801","volume":"11","author":"J Price","year":"2023","unstructured":"Price J, Gurley N, Gyapong M, Ansah EK, Awusabo-Asare K, Gyasi SF, et al. Acceptance of and adherence to a four-dose RTS, S\/AS01 schedule: findings from a longitudinal qualitative evaluation study for the malaria vaccine implementation programme. Vaccines. 2023;11: 1801.","journal-title":"Vaccines"},{"key":"5484_CR18","doi-asserted-by":"publisher","first-page":"e672","DOI":"10.1016\/S2214-109X(24)00013-5","volume":"12","author":"J Hill","year":"2024","unstructured":"Hill J, Bange T, Hoyt J, Kariuki S, Jalloh MF, Webster J, Okello G. Integration of the RTS, S\/AS01 malaria vaccine into the Essential Programme on Immunisation in western Kenya: a qualitative longitudinal study from the health system perspective. Lancet Glob Health. 2024;12:e672\u201384.","journal-title":"Lancet Glob Health"},{"key":"5484_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12936-022-04378-1","volume":"21","author":"D Yeboah","year":"2022","unstructured":"Yeboah D, Owusu-Marfo J, Agyeman YN. Predictors of malaria vaccine uptake among children 6\u201324 months in the Kassena Nankana Municipality in the Upper East Region of Ghana. Malar J. 2022;21:339.","journal-title":"Malar J"},{"key":"5484_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12936-022-04168-9","volume":"21","author":"J Grant","year":"2022","unstructured":"Grant J, Gyan T, Agbokey F, Webster J, Greenwood B, Asante KP. Challenges and lessons learned during the planning and early implementation of the RTS, S\/AS01E malaria vaccine in three regions of Ghana: a qualitative study. Malar J. 2022;21:147.","journal-title":"Malar J"},{"key":"5484_CR21","doi-asserted-by":"publisher","first-page":"205520762312112","DOI":"10.1177\/20552076231211276","volume":"9","author":"SK Seaneke","year":"2023","unstructured":"Seaneke SK, Darko DM, Nkansah E, Asamoa-Amoakohene A, Ashie A, Sampson Ewudzie J, et al. First results from the lessons learnt from the deployment of the Med Safety App for reporting adverse drug reactions in Ghana. Digit Health. 2023;9:20552076231211276.","journal-title":"Digit Health"},{"key":"5484_CR22","unstructured":"Ashie A, Mandale M, Ndalama A, Darko D, Seaneke S, Boateng EK, et al. Safety Monitoring of the RTS,S\/AS01E Malaria Vaccine: Experiences and Lessons from Routine Pharmacovigilance in Ghana, Kenya, and Malawi. A Ashie pers commun. Accessed 21 May 2025."},{"key":"5484_CR23","unstructured":"Walldorf J, Mayers G, Amponsa-Achiano K, Jalang'o R, Chisema M, Khalayi L, et al. Post Introduction Evaluation (PIE) of the malaria vaccine introduced in three pilot countries (Ghana, Kenya, and Malawi) in 2021. J Walldorf pers commun. Accessed 14 July 2025."},{"key":"5484_CR24","first-page":"241","volume":"10","author":"PM Galagali","year":"2022","unstructured":"Galagali PM, Kinikar AA, Kumar VS. Vaccine hesitancy: obstacles and challenges. Curr Pediatr Rp. 2022;10:241\u20138.","journal-title":"Curr Pediatr Rp"},{"key":"5484_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e38858","volume":"10","author":"MR Adjei","year":"2024","unstructured":"Adjei MR, Tweneboah PO, Bawa JT, Baafi JV, Kubio C, Amponsa-Achiano K, et al. Trend of RTS, S vaccine uptake in the malaria vaccine implementing programme (MVIP) pilot regions, Ghana; 2019\u20132022. Heliyon. 2024;10: e38858.","journal-title":"Heliyon"},{"issue":"1","key":"5484_CR26","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12936-023-04690-4","volume":"22","author":"J Okyere","year":"2023","unstructured":"Okyere J, Bediako VB, Ackah JA, Acheampong E, Owusu BA, Agbemavi W, et al. RTS, S\/AS01E vaccine defaults in Ghana: a qualitative exploration of the perspectives of defaulters and frontline health service providers. Malar J. 2023;22(1):260.","journal-title":"Malar J"},{"key":"5484_CR27","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1186\/s12889-023-17194-2","volume":"23","author":"J Hoyt","year":"2023","unstructured":"Hoyt J, Okello G, Bange T, Kariuki S, Jalloh MF, Webster J, Hill J. RTS, S\/AS01 malaria vaccine pilot implementation in western Kenya: a qualitative longitudinal study to understand immunisation barriers and optimise uptake. BMC Public Health. 2023;23:2283.","journal-title":"BMC Public Health"},{"key":"5484_CR28","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1186\/s12913-023-09965-9","volume":"23","author":"Y Saidu","year":"2023","unstructured":"Saidu Y, Gu J, Ngenge BM, Nchinjoh SC, Adidja A, Nnang NE, et al. Assessment of immunization data management practices in Cameroon: unveiling potential barriers to immunization data quality. BMC Health Serv Res. 2023;23:1033.","journal-title":"BMC Health Serv Res"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05484-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05484-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05484-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:37:07Z","timestamp":1757309827000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05484-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5484"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05484-6","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was not required for the pilot implementation, as the RTS, Svaccine was introduced into the national immunization programmes in the three countries.Consent was, however, obtained for the independent evaluation studies, which are publishedseparately.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"244"}}